Impact of Vaping Prevention Advertisements
Impact of The Real Cost Vaping Prevention Advertisements on Adolescents
2 other identifiers
interventional
1,565
1 country
1
Brief Summary
The purpose of this randomized controlled trial is to determine whether exposure to vaping prevention advertisements (ads) reduce susceptibility to vaping among adolescents. Previous studies have been informative, but they have tended to be one-time experimental studies that do not replicate the repeated exposures to ads that people have in the real world. This study addresses this issue by repeatedly exposing participants to vaping prevention ads over time. Participants will be adolescents aged 13-17 who currently vape or who are susceptible to vaping. Participants will be randomly assigned to ad stimuli. They will be assigned to one of two The Real Cost trial arms-health harms or addiction-or to a control trial arm (probability of assignment is 1/3 for all trial arms). Participants in the study will take 4 online surveys over a 3-week period, once per week (At week 0, 1, 2, and 3). All participants will view randomized ad stimuli based on their trial arm and answer surveys items at each session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2021
CompletedFirst Posted
Study publicly available on registry
April 8, 2021
CompletedStudy Start
First participant enrolled
July 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 3, 2021
CompletedResults Posted
Study results publicly available
April 24, 2024
CompletedApril 24, 2024
March 1, 2024
4 months
April 5, 2021
January 30, 2024
March 31, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Mean Susceptibility to Vaping Score
The 3-item Susceptibility to Vaping Scale assesses the extent to which adolescents are open to vaping, using a 1 to 4 response option scale. Here, 1 indicates the lowest susceptibility to vaping, and 4 represents the highest, with higher values indicating a greater susceptibility to vaping - essentially, a worse outcome. The overall scale score is determined by averaging the scores of the three items, summing these scores and dividing by 3. This method results in a score range from a minimum of 1 to a maximum of 4.
Week 3
Secondary Outcomes (13)
Mean Attention Score
Week 2
Mean Negative Affect Score
Week 2
Mean Cognitive Elaboration Score
Week 3
Mean Social Interactions Score
Week 3
Mean Vaping Health Harm Risk Beliefs Score
Week 3
- +8 more secondary outcomes
Other Outcomes (8)
Mean Perceived Message Effectiveness Score (UNC Youth Scale)
Week 2
Mean Perceived Message Effectiveness Score (FDA Scale)
Week 2
Mean Avoidance Score
Week 2
- +5 more other outcomes
Study Arms (3)
The Real Cost vaping prevention ads - Health effects theme
EXPERIMENTALThe Real Cost vaping prevention ads - Addiction theme
EXPERIMENTALNeutral vaping ads
OTHERInterventions
Three vaping prevention video ads from the FDA's The Real Cost prevention campaign about the health harms of vaping will be shown to participants at weeks 0, 1, and 2. Ads will be shown in a random order.
Three vaping prevention video ads from the FDA's The Real Cost prevention campaign about vaping addiction will be shown to participants at week 0, 1, and 2. Ads will be shown in a random order.
Three neutral (i.e., purely informational and without graphics) vaping video ads developed by the Investigators will be shown to participants at weeks 0, 1, and 2. Ads will be shown in a random order.
Eligibility Criteria
You may qualify if:
- Between ages 13-17 years old
- Be able to read and speak English
- Be able to take an online survey in English
- Be susceptible to vaping
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UNC Lineberger Comprehensive Cancer Centerlead
- National Institutes of Health (NIH)collaborator
- Food and Drug Administration (FDA)collaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Related Publications (2)
Kieu T, Ma H, Rohde JA, Gottfredson O'Shea N, Hall MG, Brewer NT, Noar SM. Understanding Potential Mechanisms of Vaping Prevention Messages: A Mediation Analysis of the Real Cost Campaign Advertisements. Health Educ Behav. 2025 Feb;52(1):102-112. doi: 10.1177/10901981241278565. Epub 2024 Sep 29.
PMID: 39342464DERIVEDNoar SM, Gottfredson NC, Kieu T, Rohde JA, Hall MG, Ma H, Fendinger NJ, Brewer NT. Impact of Vaping Prevention Advertisements on US Adolescents: A Randomized Clinical Trial. JAMA Netw Open. 2022 Oct 3;5(10):e2236370. doi: 10.1001/jamanetworkopen.2022.36370.
PMID: 36227597DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Seth M. Noar
- Organization
- University of North Carolina at Chapel Hill
Study Officials
- PRINCIPAL INVESTIGATOR
Seth Noar, PhD
University of North Carolina, Chapel Hill
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2021
First Posted
April 8, 2021
Study Start
July 3, 2021
Primary Completion
November 3, 2021
Study Completion
November 3, 2021
Last Updated
April 24, 2024
Results First Posted
April 24, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- 9 to 36 months following publication
- Access Criteria
- Investigator who proposes to use the data has approval from an IRB, IEC, or REB, as applicable, and an executed data use/sharing agreement with UNC.
Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.